These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23893381)

  • 1. Association of myeloperoxidase with ovarian cancer.
    Castillo-Tong DC; Pils D; Heinze G; Braicu I; Sehouli J; Reinthaller A; Schuster E; Wolf A; Watrowski R; Maki RA; Zeillinger R; Reynolds WF
    Tumour Biol; 2014 Jan; 35(1):141-8. PubMed ID: 23893381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
    Polonikov AV; Solodilova MA; Ivanov VP
    J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.
    Weng KP; Hsieh KS; Huang SH; Wu HW; Chien JH; Lin CC; Tang CW; Ou SF; Huang SJ; Ger LP
    J Microbiol Immunol Infect; 2016 Oct; 49(5):788-796. PubMed ID: 26066543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.
    Yang JP; Wang WB; Yang XX; Yang L; Ren L; Zhou FX; Hu L; He W; Li BY; Zhu Y; Jiang HG; Zhou YF
    PLoS One; 2013; 8(6):e65778. PubMed ID: 23840365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.
    Reynolds WF; Sermet-Gaudelus I; Gausson V; Feuillet MN; Bonnefont JP; Lenoir G; Descamps-Latscha B; Witko-Sarsat V
    Mediators Inflamm; 2006; 2006(2):36735. PubMed ID: 16883063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population.
    Hou X; Gao Y; Duan Y; Wang Z; Shi L; Ma J; Xie X
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C97-100. PubMed ID: 26323935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
    Lu W; Xing D; Qi J; Tan W; Miao X; Lin D
    Int J Cancer; 2002 Nov; 102(3):275-9. PubMed ID: 12397651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients.
    Doi K; Noiri E; Maeda R; Nakao A; Kobayashi S; Tokunaga K; Fujita T
    Hypertens Res; 2007 Dec; 30(12):1193-8. PubMed ID: 18344624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
    Xu LL; Liu G; Miller DP; Zhou W; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1555-9. PubMed ID: 12496043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.
    Wenham RM; Calingaert B; Ali S; McClean K; Whitaker R; Bentley R; Lancaster JM; Schildkraut J; Marks J; Berchuck A
    J Soc Gynecol Investig; 2003 Sep; 10(6):381-7. PubMed ID: 12969782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
    Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
    Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.
    Jiang Z; Zhang Z; Wang Z; Zhang G; Hu K; He B; Wang S
    Hepatogastroenterology; 2012 May; 59(115):757-61. PubMed ID: 22094928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis.
    Osterreicher CH; Datz C; Stickel F; Hellerbrand C; Penz M; Hofer H; Wrba F; Penner E; Schuppan D; Ferenci P
    J Hepatol; 2005 Jun; 42(6):914-9. PubMed ID: 15885363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
    Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
    Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.
    Kantarci OH; Lesnick TG; Yang P; Meyer RL; Hebrink DD; McMurray CT; Weinshenker BG
    Mayo Clin Proc; 2002 Jan; 77(1):17-22. PubMed ID: 11794452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
    Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
    Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
    Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
    BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.
    Hefler LA; Ludwig E; Lebrecht A; Zeillinger R; Tong-Cacsire D; Koelbl H; Leodolter S; Tempfer CB
    J Soc Gynecol Investig; 2002; 9(6):386-90. PubMed ID: 12445604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
    Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
    Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.